TY - JOUR
T1 - Titin genemutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy
AU - Van Spaendonck-Zwarts, Karin Y.
AU - Posafalvi, Anna
AU - Van Den Berg, Maarten P.
AU - Hilfiker-Kleiner, Denise
AU - Bollen, Ilse A.E.
AU - Sliwa, Karen
AU - Alders, Mariëlle
AU - Almomani, Rowida
AU - Van Langen, Irene M.
AU - Van Der Meer, Peter
AU - Sinke, Richard J.
AU - Van Der Velden, Jolanda
AU - Van Veldhuisen, Dirk J.
AU - Van Tintelen, J. Peter
AU - Jongbloed, Jan D.H.
PY - 2014/8/21
Y1 - 2014/8/21
N2 - Aim: Peripartum cardiomyopathy (PPCM) can be an initial manifestation of familial dilated cardiomyopathy (DCM).We aimed to identify mutations in families that could underlie their PPCM and DCM. Methods and results: We collected 18 families withPPCMandDCMcases from various countries.We studied the clinical characteristics of the PPCMpatients and affected relatives, and applied a targeted next-generation sequencing (NGS) approach to detect mutations in 48 genes known to be involved in inherited cardiomyopathies.We identified 4 pathogenic mutations in 4 of 18 families (22%): 3 in TTN and 1 in BAG3. In addition, we identified 6 variants of unknown clinical significance that may be pathogenic in 6 other families (33%): 4 in TTN, 1 in TNNC1, and 1 in MYH7. Measurements of passive force in single cardiomyocytes and titin isoform composition potentially support an upgrade of one of the variants of unknown clinical significance in TTN to a pathogenic mutation. Only 2 of 20 PPCM cases in these families showed the recovery of left ventricular function. Conclusion: Targeted NGS shows that potentially causal mutations in cardiomyopathy-related genes are common in families with both PPCM and DCM. This supports the earlier finding thatPPCM can be part of familial DCM. Our cohort is particularly characterized by a high proportion of TTN mutations and a low recovery rate in PPCM cases.
AB - Aim: Peripartum cardiomyopathy (PPCM) can be an initial manifestation of familial dilated cardiomyopathy (DCM).We aimed to identify mutations in families that could underlie their PPCM and DCM. Methods and results: We collected 18 families withPPCMandDCMcases from various countries.We studied the clinical characteristics of the PPCMpatients and affected relatives, and applied a targeted next-generation sequencing (NGS) approach to detect mutations in 48 genes known to be involved in inherited cardiomyopathies.We identified 4 pathogenic mutations in 4 of 18 families (22%): 3 in TTN and 1 in BAG3. In addition, we identified 6 variants of unknown clinical significance that may be pathogenic in 6 other families (33%): 4 in TTN, 1 in TNNC1, and 1 in MYH7. Measurements of passive force in single cardiomyocytes and titin isoform composition potentially support an upgrade of one of the variants of unknown clinical significance in TTN to a pathogenic mutation. Only 2 of 20 PPCM cases in these families showed the recovery of left ventricular function. Conclusion: Targeted NGS shows that potentially causal mutations in cardiomyopathy-related genes are common in families with both PPCM and DCM. This supports the earlier finding thatPPCM can be part of familial DCM. Our cohort is particularly characterized by a high proportion of TTN mutations and a low recovery rate in PPCM cases.
KW - Cardiomyopathy
KW - Genetics
KW - Peripartum cardiomyopathy
KW - Pregnancy
KW - Titin
UR - http://www.scopus.com/inward/record.url?scp=84906047643&partnerID=8YFLogxK
U2 - 10.1093/eurheartj/ehu050
DO - 10.1093/eurheartj/ehu050
M3 - Article
C2 - 24558114
AN - SCOPUS:84906047643
SN - 0195-668X
VL - 35
SP - 2165
EP - 2173
JO - European Heart Journal
JF - European Heart Journal
IS - 32
ER -